Logo
BridgeBio Pharma

Sr. Medical Director, Medical Affairs (Achondroplasia Lead) Remote - United Stat

BridgeBio Pharma, Baltimore, Maryland, United States,


About QED Therapeutics & BridgeBio PharmaQED Therapeutics, an affiliate of BridgeBio Pharma , focuses on developing targeted treatments for FGFR-driven skeletal dysplasias, particularly Achondroplasia. Achondroplasia is the most common form of genetically-driven short stature, which causes potentially debilitating medical complications. With our experimental therapeutic candidate, infigratinib, we seek to provide an option to children living with Achondroplasia and their families.Our business is inspired by our values:PUT PATIENTS FIRSTEVERY MINUTE COUNTSTHINK INDEPENDENTLYBE RADICALLY TRANSPARENTFGFR=fibroblast growth factor receptor.BridgeBio

is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, Raleigh, and with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zug, Switzerland, and are expanding across Europe.The Sr. Medical Director, Medical Affairs will play an essential role in the planning, implementation, and daily operation of drug development program(s). This role is ultimately responsible for supporting the launch of infigratinib for achondroplasia. The Sr. Medical Director will collaborate with key internal and external stakeholders to support the achondroplasia program, contributing scientific knowledge and expertise. Responsible for providing medical support to QED pipeline development, clinical strategy, and post-marketing commitments while supporting Medical Affairs strategy related to Investigator Sponsored Trials.Responsibilities

Develop medical content and lead the organization of advisory boards and symposia in support of pipeline programsEngage with investigative sites, clinical consultants, Key Opinion Leaders (KOLs), and the research community to support company initiativesDevelop a training curriculum for new hiresMedical reviewer and approver for Medical, Commercial, and Advocacy contentCo-develop Field Medical strategy with the Senior Field Medical/MSL Team leadContribute to and collaborate with clinical development on ongoing and planned clinical trials (phases 2-4)Collaborate with clinical development and other cross-functional teams to establish a scientific data disclosure strategy to support registration and launch activitiesRepresent QED at scientific, clinical, and business development meetingsAssist in critically evaluating study results with study investigatorsWork with Scientific Communications to prepare publications and presentations for external meetingsFunction as the medical representative on cross-functional and project team meetingsNo matter your role at BridgeBio, successful team members are:Patient Champions, who put patients first and uphold strict ethical standardsEntrepreneurial Operators, who drive toward practical solutions and have an ownership mindsetTruth Seekers, who are detailed, rational, and humble problem solversIndividuals Who Inspire Excellence in themselves and those around themHigh-quality executors, who execute against goals and milestones with quality, precision, and speedEducation, Experience & Skills Requirements

MD, PharmD, or equivalent7 (or more) years of experience in drug development, either within the industry or as a clinical investigator/physician-scientist in academia, or equivalent experienceExperience in rare disease fields and pediatric endocrinology is a plusStrong interpersonal and leadership skillsSkilled in clinical research and an understanding of the process of pharmaceutical product development and approvalExperience in product launch development and execution is highly desirableExperience in strategy and execution preferredKnowledge of regulations impacting Medical Affairs and field activities in the pharmaceutical industry is criticalDemonstrated ability to organize, prioritize, and work effectively with minimal supervision in a constantly changing environmentAbility to work independently in a fast-paced environmentExcellent written and verbal communication skillsMay travel up to 40% domestically and internationally for scientific meetings, advisory boards, etc; evening and weekend work will be involved with some variation based upon the demands of the business imperativesWhat We Offer

Patient Days, where we hear directly from individuals living with the conditions we are seeking to impact throughout the yearA culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speakAn unyielding commitment to always putting patients first. Learn more about how we do this

hereA decentralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the scienceA place where you own the vision – both for your program and your own career pathA collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our gameAccess to learning and development resources to help you get in the best professional shape of your lifeRobust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)Flexible PTORapid career advancement for strong performersPotential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over timeCommitment to Diversity, Equity & Inclusion

#J-18808-Ljbffr